1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
2
|
Walsh T, Casadei S, Coats KH, Swisher E,
Stray SM, Higgins J, Roach KC, Mandell J, Lee MK, Ciernikova S, et
al: Spectrum of mutations in BRCA1, BRCA2, CHEK2 and TP53 in
families at high risk of breast cancer. JAMA. 295:1379–1388. 2006.
View Article : Google Scholar : PubMed/NCBI
|
3
|
Mantzourani M, Gogas H, Katsandris A and
Meletis J: Severe thrombocytopenia related to trastuzumab infusion.
Med Sci Monit. 17:CS85–CS87. 2011. View Article : Google Scholar : PubMed/NCBI
|
4
|
Nunes FD, de Almeida FC, Tucci R and de
Sousa SC: Homeobox genes: A molecular link between development and
cancer. Pesqui Odontol Bras. 17:94–98. 2003. View Article : Google Scholar
|
5
|
Grier DG, Thompson A, Kwasniewska A,
McGonigle GJ, Halliday HL and Lappin TR: The pathophysiology of HOX
genes and their role in cancer. J Pathol. 205:154–171. 2005.
View Article : Google Scholar : PubMed/NCBI
|
6
|
Bhatlekar S, Fields JZ and Boman BM: HOX
genes and their role in the development of human cancers. J Mol Med
(Berl). 92:811–823. 2014. View Article : Google Scholar
|
7
|
Nguyen Kovochich A, Arensman M, Lay AR,
Rao NP, Donahue T, Li X, French SW and Dawson DW: HOXB7 promotes
invasion and predicts survival in pancreatic adenocarcinoma.
Cancer. 119:529–539. 2013. View Article : Google Scholar
|
8
|
Cantile M, Pettinato G, Procino A,
Feliciello I, Cindolo L and Cillo C: In vivo expression of the
whole HOX gene network in human breast cancer. Eur J Cancer.
39:257–264. 2003. View Article : Google Scholar : PubMed/NCBI
|
9
|
McGinnis W and Krumlauf R: Homeobox genes
and axial patterning. Cell. 68:283–302. 1992. View Article : Google Scholar : PubMed/NCBI
|
10
|
Pineault N, Abramovich C, Ohta H and
Humphries RK: Differential and common leukemogenic potentials of
multiple NUP98-Hox fusion proteins alone or with Meis1. Mol Cell
Biol. 24:1907–1917. 2004. View Article : Google Scholar : PubMed/NCBI
|
11
|
Hong JH, Lee JK, Park JJ, Lee NW, Lee KW
and Na JY: Expression pattern of the class I homeobox genes in
ovarian carcinoma. J Gynecol Oncol. 21:29–37. 2010. View Article : Google Scholar : PubMed/NCBI
|
12
|
Chile T, Fortes MA, Corrêa-Giannella ML,
Brentani HP, Maria DA, Puga RD, de Paula Vde J, Kubrusly MS, Novak
EM, Bacchella T, et al: HOXB7 mRNA is overexpressed in pancreatic
ductal adenocarcinomas and its knockdown induces cell cycle arrest
and apoptosis. BMC Cancer. 13:4512013. View Article : Google Scholar : PubMed/NCBI
|
13
|
Chen KN, Gu ZD, Ke Y, Li JY, Shi XT and Xu
GW: Expression of 11 HOX genes is deregulated in esophageal
squamous cell carcinoma. Clin Cancer Res. 11:1044–1049.
2005.PubMed/NCBI
|
14
|
De Souza Setubal Destro MF, Bitu CC,
Zecchin KG, Graner E, Lopes MA, Kowalski LP and Coletta RD:
Overexpression of HOXB7 homeobox gene in oral cancer induces
cellular proliferation and is associated with poor prognosis. Int J
Oncol. 36:141–149. 2010.
|
15
|
Naora H, Yang YQ, Montz FJ, Seidman JD,
Kurman RJ and Roden RB: A serologically identified tumor antigen
encoded by a homeobox gene promotes growth of ovarian epithelial
cells. Proc Natl Acad Sci USA. 98:4060–4065. 2001. View Article : Google Scholar : PubMed/NCBI
|
16
|
Wu X, Chen H, Parker B, Rubin E, Zhu T,
Lee JS, Argani P and Sukumar S: HOXB7, a homeodomain protein, is
overexpressed in breast cancer and confers epithelial-mesenchymal
transition. Cancer Res. 66:9527–9534. 2006. View Article : Google Scholar : PubMed/NCBI
|
17
|
Chen H, Lee JS, Liang X, Zhang H, Zhu T,
Zhang Z, Taylor ME, Zahnow C, Feigenbaum L, Rein A, et al: Hoxb7
inhibits transgenic HER-2/neu-induced mouse mammary tumor onset but
promotes progression and lung metastasis. Cancer Res. 68:3637–3644.
2008. View Article : Google Scholar : PubMed/NCBI
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)). Methods. 25:402–408. 2001. View Article : Google Scholar
|
19
|
Vogelstein B and Kinzler KW: The multistep
nature of cancer. Trends Genet. 9:138–141. 1993. View Article : Google Scholar : PubMed/NCBI
|
20
|
Raman V, Martensen SA, Reisman D, Evron E,
Odenwald WF, Jaffee E, Marks J and Sukumar S: Compromised HOXA5
function can limit p53 expression in human breast tumours. Nature.
405:974–978. 2000. View
Article : Google Scholar : PubMed/NCBI
|
21
|
Chu MC, Selam FB and Taylor HS: HOXA10
regulates p53 expression and matrigel invasion in human breast
cancer cells. Cancer Biol Ther. 3:568–572. 2004. View Article : Google Scholar : PubMed/NCBI
|
22
|
Jansen MP, Sieuwerts AM, Look MP, Ritstier
K, Meijer-van Gelder ME, van Staveren IL, Klijn JG, Foekens JA and
Berns EM: HOXB13-to-IL17BR expression ratio is related with tumor
aggressiveness and response to tamoxifen of recurrent breast
cancer: A retrospective study. J Clin Oncol. 25:662–668. 2007.
View Article : Google Scholar : PubMed/NCBI
|
23
|
Shah N, Jin K, Cruz LA, Park S, Sadik H,
Cho S, Goswami CP, Nakshatri H, Gupta R, Chang HY, et al: HOXB13
mediates tamoxifen resistance and invasiveness in human breast
cancer by suppressing ERα and inducing IL-6 expression. Cancer Res.
73:5449–5458. 2013. View Article : Google Scholar : PubMed/NCBI
|
24
|
Krumlauf R: Hox genes in vertebrate
development. Cell. 78:191–201. 1994. View Article : Google Scholar : PubMed/NCBI
|
25
|
Garaulet DL, Castellanos MC, Bejarano F,
Sanfilippo P, Tyler DM, Allan DW, Sánchez-Herrero E and Lai EC:
Homeotic function of Drosophila Bithorax-complex miRNAs mediates
fertility by restricting multiple Hox genes and TALE cofactors in
the CNS. Dev Cell. 29:635–648. 2014. View Article : Google Scholar : PubMed/NCBI
|
26
|
Bhatlekar S, Addya S, Salunek M, Orr CR,
Surrey S, McKenzie S, Fields JZ and Boman BM: Identification of a
developmental gene expression signature, including HOX genes, for
the normal human colonic crypt stem cell niche: Overexpression of
the signature parallels stem cell overpopulation during colon
tumorigenesis. Stem Cells Dev. 23:167–179. 2014. View Article : Google Scholar :
|
27
|
Cantile M, Scognamiglio G, La Sala L, La
Mantia E, Scaramuzza V, Valentino E, Tatangelo F, Losito S,
Pezzullo L, Chiofalo MG, et al: Aberrant expression of posterior
HOX genes in well differentiated histotypes of thyroid cancers. Int
J Mol Sci. 14:21727–21740. 2013. View Article : Google Scholar : PubMed/NCBI
|
28
|
Caré A, Silvani A, Meccia E, Mattia G,
Stoppacciaro A, Parmiani G, Peschle C and Colombo MP: HOXB7
constitutively activates basic fibroblast growth factor in
melanomas. Mol Cell Biol. 16:4842–4851. 1996.PubMed/NCBI
|
29
|
Caré A, Silvani A, Meccia E, Mattia G,
Peschle C and Colombo MP: Transduction of the SkBr3 breast
carcinoma cell line with the HOXB7 gene induces bFGF expression,
increases cell proliferation and reduces growth factor dependence.
Oncogene. 16:3285–3289. 1998. View Article : Google Scholar : PubMed/NCBI
|
30
|
Liao WT, Jiang D, Yuan J, Cui YM, Shi XW,
Chen CM, Bian XW, Deng YJ and Ding YQ: HOXB7 as a prognostic factor
and mediator of colorectal cancer progression. Clin Cancer Res.
17:3569–3578. 2011. View Article : Google Scholar : PubMed/NCBI
|
31
|
Carè A, Felicetti F, Meccia E, Bottero L,
Parenza M, Stoppacciaro A, Peschle C and Colombo MP: HOXB7: A key
factor for tumor-associated angiogenic switch. Cancer Res.
61:6532–6539. 2001.PubMed/NCBI
|
32
|
Boström K, Tintut Y, Kao SC, Stanford WP
and Demer LL: HOXB7 overexpression promotes differentiation of
C3H10T1/2 cells to smooth muscle cells. J Cell Biochem. 78:210–221.
2000. View Article : Google Scholar : PubMed/NCBI
|